首页> 外文期刊>Journal of Materials Chemistry, B. materials for biology and medicine >Dual endogenous stimuli-responsive polyplex micelles as smart two-step delivery nanocarriers for deep tumor tissue penetration and combating drug resistance of cisplatin
【24h】

Dual endogenous stimuli-responsive polyplex micelles as smart two-step delivery nanocarriers for deep tumor tissue penetration and combating drug resistance of cisplatin

机译:双内源性刺激响应多聚体胶束作为智能两步递送纳米载体,可深入肿瘤组织渗透并对抗顺铂的耐药性

获取原文
获取原文并翻译 | 示例
           

摘要

Massive delivery of therapeutics throughout tumors and efficient cellular internalization into tumor cells remain the major obstacles for polymeric drug delivery system in the treatment of drug-resistant cancers. To address these issues, we strategically programmed dual stimuli-responsive polyplex micelles as drug delivery systems from self-assembly of anionic block copolymers, poly(ethylene glycol)-polyt(N'-dimethylmaleoyl-2-aminoethyl)aspartamide] (PEG-PAsp(EDA-DM)), and platinum(IV)-conjugated cationic poly(amidoamine) (PAMAM-Pt(IV)) dendrimer prodrugs. It is noteworthy that the chemical design for anionic block copolymers affords intriguing charge conversional function in response to a mild acidic environment at the tumor site (pH ~ 6.8), thereby permitting rapid disassembly of polyplex micelle as a result of electrostatic repulsion. Thus, PAMAM-Pt(IV) prodrugs released in the form of individual molecules exert deep penetration and good dispersion activity in the tumor tissue by virtue of their small size and high mobility. Furthermore, the well-dispersed positively charged PAMAM dendrimers owing to their high affinity to the negatively charged cellular membrane are efficiently internalized into the tumor cells, followed by release of active cisplatin drug in the reductive cytosol. Accordingly, the drug resistance of cisplatin can be addressed. This proof-of-concept anticancer drug delivery platform provides a unique two-step delivery of anti-cancer drugs for the pursuit of deep tumor tissue penetration and overcoming drug resistance.
机译:整个肿瘤中大量治疗剂的递送以及肿瘤细胞中有效的细胞内在化仍然是聚合物药物递送系统在耐药性癌症治疗中的主要障碍。为了解决这些问题,我们从阴离子嵌段共聚物的自组装,聚(乙二醇)-聚(N'-二甲基马来酰基-2-氨基乙基)天冬酰胺](PEG-PAsp (EDA-DM))和铂(IV)共轭的阳离子聚(酰胺基胺)(PAMAM-Pt(IV))树状大分子前药。值得注意的是,阴离子嵌段共聚物的化学设计提供了有趣的电荷转化功能,以响应肿瘤部位的温和酸性环境(pH〜6.8),从而由于静电排斥作用而迅速解离了复合胶束。因此,以单个分子形式释放的PAMAM-Pt(IV)前药由于其小尺寸和高迁移率而在肿瘤组织中发挥了深层渗透和良好的分散活性。此外,由于它们对带负电的细胞膜具有高亲和力,所以分散良好的带正电的PAMAM树状聚合物被有效地内化到肿瘤细胞中,随后在还原性胞质溶胶中释放出活性顺铂药物。因此,可以解决顺铂的耐药性。这个概念验证的抗癌药物输送平台可提供独特的两步式抗癌药物输送,以实现深层肿瘤组织渗透和克服耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号